The Cystic Fibrosis Foundation and Vertex Pharmaceuticals of Cambridge, Mass. have announced a successful trial for a new drug that treats the underlying cause of cystic fibrosis.
About 30,000 people in the United States have CF, which is caused by a genetic mutation that creates a buildup of thick mucus in the lungs and digestive system. People with CF rarely live beyond their mid-30′s. Drugs currently on the market only treat symptoms of the disease, while the new medication targets the defective protein that causes it.
Patients in the study experienced dramatic improvements in lung function and weight gain. We speak with one of them, Emily Schaller of Detroit, who is breathing better than she can ever remember.
Jeremy Hobson joins Robin Young as co-host of Here & Now in its new 2-hour format, from WBUR and NPR.
The organizers of the Boston Marathon have issued special invitations to 450 people who made the case they were profoundly affected by the bombings in April.2 Comments | more »
Almost a year after 20 children and six educators were killed at Sandy Hook Elementary School, some states have toughened gun rules, while others have loosened them.137 Comments | more »
As the BBC’s State Department correspondent, Kim Ghattas has traveled hundreds of thousands of miles with U.S. secretaries of state, including Condoleezza Rice, Hillary Clinton and John Kerry.1 Comment | more »